Among the synthesised over 2,000 compounds1} of the structure similar to chloramphenicol, only three found use in therapy: thiamphenicol, azidamphenicol and florfenicol 2' 3). Chloramphenicol esters are also used. The only derivative with the activity greater than chloramphenicol is perchlorylchloramphenicol (-NO2->-C1O3), a compoundpossessing explosive properties4). The heteroaromatic analogs of chloramphenicol are insignificantly active or inactive.
The only exception is the thiophene analogue, DL-threo-l-
with the activity of 50% in relation to the racemic chloramphenicol5). Pyrrole analogs are not known. Remote toxicity, specific for chloramphenicol, is probably caused by the presence of a fragment of nitrobenzene, which is subject to metabolisation to, among others, an aniline derivative (-C6H4-NO2->-C6H4NH2) and other metabolites of the nitro group.6) The substitution of either the nitro group or the benzene ring by other fragments of the molecule shall result in different metabolites with perhaps a reduced or eliminated remote toxicity.
In the present paper we are presenting the synthesis of two pyrrole analogs of chloramphenicol, compounds7 and 13 (Scheme 1). We had expected that the presence of the V-Methylpyrrole was the substrate, which was subject to reaction with bromoacetyl bromide in the presence of AICI3. The obtained crude 2-bromoacetyl-l -methylpyrrole 1 was nitrated, obtaining a mixture of 2-bromoacetyl-1-methyl-4-nitropyrole 2 and 2-bromoacetyl-l-methyl-5-nitropyrrole 8. These compoundswere separated by means of column chromatography (silicagel, C6H6/CH2C12= 1 : 1). The transformation of the two bromoketones into the target compounds 7 and 13 was conducted by means of the modified methods of Sorm8) and Smolenski9), used in the industrial production of chloramphenicol. Compound2 was then subject to reaction with hexamethylenetetraamine, obtaining quaternary ammoniumsalt 3, which, in turn, was transformed into aminoketone 4 in result of hydrolysis (HC1/H2O-EtOH). This compound was further transformed into amide 5 by means of dichloroacetyl chloride and was hydroxymethylated while the product of reaction 6 was subject to Meerwein-Ponndorff reduction. The use of this method selectively results in a compound 7 with the desired DL-threo configuration, with a minimumaddition of the dlerythro product. Nitroketone 8 was identically transformed into compound13. The structures of compounds2-13 were confirmed by means of lU NMRand 13C NMRspectrometry. The threo Hz1}. The direct comparison of the !H and 13C NMRspectra of compounds 7 and 13 with chloramphenicol spectra have shownsignificant similarity of their aliphatic fragments. The antibacterial activity of compounds 7 and 13 was determined using the method presented by Sahm11}. The obtained initial results allow to state that the racemic compound 7 shows the activity 4-16 times smaller than that of chloramphenicol; when calculated into the included D-threo enantiometer -2 to 8 times smaller. Compound13 (DL-threo) presents the selective significant activity only with regard to strains from the Enterobacteriaceae family.
